**Core Concept**
The underlying principle being tested is the **metabolic pathway of tyrosine**, specifically the breakdown of tyrosine in the liver. This process involves several enzymes, one of which is **Homogentisate 1,2-dioxygenase (HGD)**, also known as Homogentisate oxidase.

**Why the Correct Answer is Right**
The correct answer is related to **Alkaptonuria**, a condition characterized by the accumulation of **homogentisic acid** due to the deficiency of Homogentisate 1,2-dioxygenase. This enzyme is crucial for the conversion of homogentisic acid to **maleylacetoacetic acid** in the tyrosine catabolic pathway. Without it, homogentisic acid accumulates and is oxidized to a benzoquinone acetic acid, leading to the darkening of urine when exposed to air and other clinical manifestations.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not directly relate to the lack of Homogentisate oxidase enzyme.
**Option B:** Similarly, this option is incorrect as it is not associated with the specific enzyme deficiency in question.
**Option C:** This option is also incorrect because it does not accurately describe the condition resulting from the lack of Homogentisate oxidase.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **Alkaptonuria** leads to the accumulation of homogentisic acid, which can cause **ochronosis** (a bluish-black pigmentation in connective tissues) and **arthritis** due to the deposition of oxidized homogentisic acid in cartilages and other tissues.

**Correct Answer:** D. Alkaptonuria